Investment pays off for Cyprotex
BIOTECHNOLOGY business Cyprotex says its investment in technology and equipment is paying off as it continues to perform strongly.
kSectionSeparatorToken Deputy Editor, North West DRUG testing specialist Cyprotex has warned profits will be below market expectations due to ``softer'' second half revenues.The Macclesfield firm, which develops software used by large pharmaceutical groups to predict the effect of medication, said its performance had been affected in recent weeks by pre-Christmas customer delays.In a trading statement the group said: ``While revenues up to the month of October were as expected, late November and December performance have been slightly softer than expected due to a delay in customers......for the full story register now for free or login below...